【2h】

Visceral Hyperalgesia

机译:内脏痛觉过敏

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Visceral hyperalgesia refers to increased pain sensation in response to gastrointestinal sensory stimulus. In neonates with neurological impairments, gabapentin has been successfully used as a treatment for visceral hyperalgesia in neonates. The authors describe a preterm infant with myelomeningocele and persistent neuropathic pain that manifested as irritability, hypertonicity, poor weight gain, and feeding intolerance. After exclusion of other etiologies, the diagnosis of visceral hyperalgesia was suspected and the infant was treated with gabapentin. Following appropriate titration to effect and close monitoring of side effects of gabapentin, he subsequently demonstrated improved tone, decreased irritability with feedings, and appropriate weight gain. In addition, the authors provide a review of the available literature of gabapentin use in neonates and offer suggestions on when to consider starting gabapentin in a neonate with neurological impairment and chronic unexplained gastrointestinal manifestations.
机译:内脏痛觉过敏是指响应胃肠道感觉刺激而增加的疼痛感。在神经功能受损的新生儿中,加巴喷丁已成功地用作新生儿内脏痛觉过敏的治疗方法。这组作者描述了早产儿患有脊髓膜脑膜膨出和持续性神经性疼痛,表现为烦躁,高渗,体重增加不良和喂养不耐受。排除其他病因后,怀疑可诊断为内脏痛觉过敏,并对该婴儿进行了加巴喷丁治疗。在适当滴定效果并密切监测加巴喷丁的副作用后,他随后表现出语气改善,进食时烦躁不安和体重增加。此外,作者对新生儿使用加巴喷丁的文献进行了综述,并就何时考虑在神经功能障碍和慢性肠胃功能不明的新生儿中开始使用加巴喷丁提供了建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号